Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Potomac Health News.
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
GlobeNewswire, Inc.
·
August 30, 2025
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to Host Investor Event and Webcast Tuesday September 2, 2025, at 8:00 AM...
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
GlobeNewswire, Inc.
·
August 29, 2025
IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global...
Carahsoft Sponsors 16th Annual Billington Cybersecurity Summit in Washington, D.C. September 9-12, 2025
GlobeNewswire, Inc.
·
August 26, 2025
RESTON, Va., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, will be joined by more than 95 of its technology and reseller partners at the 16th Annual Billington Cybersecurity Summit,...
Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
August 28, 2025
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced...
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
GlobeNewswire, Inc.
·
August 28, 2025
LEXINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range...
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
August 28, 2025
VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5...
Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
GlobeNewswire, Inc.
·
August 28, 2025
CHATHAM, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today...
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
GlobeNewswire, Inc.
·
August 28, 2025
CHAPEL HILL, N.C., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary...
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
August 28, 2025
PHILADELPHIA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will...
Supernus Pharmaceuticals to Participate in September Investor Conferences
GlobeNewswire, Inc.
·
August 27, 2025
ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced...
Quest PharmaTech Announces Results from AGM
GlobeNewswire, Inc.
·
August 27, 2025
EDMONTON, Alberta, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its August 25, 2025 annual general meeting of shareholders. The Company announces the following 4...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
GlobeNewswire, Inc.
·
August 27, 2025
US Food and Drug Administration (FDA) has granted Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression. NRx Pharmaceuticals is making NRX-100 available on an expanded...
Opus Genetics Inherited Retinal Disease Programs Featured at Medical and Industry Conferences in September
GlobeNewswire, Inc.
·
August 27, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq:IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule...
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire, Inc.
·
August 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York...
NEW: Food Allergy Emergency Care Plan Empowers Self-Care and Reduces Health Care Costs
GlobeNewswire, Inc.
·
August 27, 2025
Washington, DC, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces the availability of the first validated food allergy anaphylaxis action plan, including versions for children under age 3 and children...
Innate Healthcare Institute - 695592 - 08/15/2025
U.S. Food and Drug Administration
·
August 26, 2025
Delivery Method: VIA UPS and Electronic Mail Reference #: CBER 25-695592 Product: Biologics Recipient: Recipient Name Travis Whitney, NMD, DAASCP, MSc, MSAc Recipient Title Founder and Chief Medical Officer Innate Healthcare Institute 4835 East...
The Alternatives Foundation Launches Initiative to Bridge Critical Funding Gap in Medical and Scientific Research
EIN Presswire
·
August 27, 2025
Donate complex assets (private equity, venture capital, & closely held stock) to fuel life saving scientific research. AUSTIN, TX, UNITED STATES, August 27, 2025 /EINPresswire.com/ -- In the wake of this year’s federal research funding...
DEADLINE THIS WEEK: Berger Montague Advises Petco Health and Wellness Company (NASDAQ: WOOF) Investors to Contact the Firm Before August 29, 2025
GlobeNewswire, Inc.
·
August 26, 2025
PHILADELPHIA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Berger Montague, a nationally recognized securities litigation law firm, is investigating potential securities law violations involving Petco Health and Wellness Company, Inc. (“Petco” or the...
Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
GlobeNewswire, Inc.
·
August 26, 2025
Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc....
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine
GlobeNewswire, Inc.
·
August 26, 2025
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease,...